Who owns Akari Therapeutics?

Tip: Access positions for across all investors

Analyze quarterly positions in Akari Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Akari Therapeutics stock

Who bought or sold Akari Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cornerstone Planning Group 5.00 $16.000000 100% Dec 2023
 View chart